Guest Post by Michael A. Caligiuri, MD Last year, the U.S. Food and Drug Administration approved 15 new anticancer therapeutics. More groundbreaking treatments are on the way. Despite this progress, cancer still has a disproportionate impact on disadvantaged and minority groups. In the U.S., black men face more than doubleRead More →
Neuroblastoma Neuroblastoma is the most common form of cancer in children under the age of one, and accounts for about 6% of all types of childhood cancers. It develops in neuroblasts, or immature nerve cells, that should eventually mature into nerve cells. In most cases, neuroblastoma is detected after aRead More →
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer therapeutics and expanded the use of some previously approved anticancer therapeutics to include new types of cancer. Specifically, the agency approved a new combination of molecularly targeted therapeutics—encorafenib (Braftovi) and binimetinibRead More →
Biopsies have been an integral part of cancer care for decades. In undiagnosed patients, oncologists can examine suspicious tissues and determine if the cells are benign or malignant. Following diagnosis, biopsies can reveal additional information about a patient’s tumor – What mutations are driving this cancer? Is this patient likelyRead More →
About Childhood Leukemia Cancer Leukemia is the most common form of childhood cancer today, accounting for nearly one-third of all childhood cancer diagnoses in the United States. A blood-based cancer that begins in the soft inner part of the bone called the bone marrow, childhood leukemia is classified into threeRead More →
Loriana Hernandez-Aldama is an Emmy Award-winning journalist and former news anchor and medical reporter turned cancer survivor, advocate, and speaker. After being diagnosed with acute myeloid leukemia, she launched ArmorUp for LIFE, a nonprofit organization that encourages people to change their lives through diet, exercise, and lifestyle before a life-threateningRead More →
Dr. William Breitbart is Chairman of the Jimmie C. Holland Chair in Psychiatric Oncology and is the Attending Psychiatrist, Psychiatry Service, in the Department of Psychiatry & Behavioral Sciences at Memorial Sloan Kettering Cancer Center (MSKCC). He’s also Attending Psychiatrist, Supportive Care Service, in the Department of Medicine at MSKCCRead More →
Due to the many advances in cancer treatment, people are increasingly living for a long time after their diagnosis by having ongoing treatment, called extended treatment. For example, a person with chronic myelogenous leukemia may take oral medications for decades and perhaps for the rest of that person’s life. ARead More →
Enrique Soto, MD, is a medical oncologist specializing in the care of older adults with cancer. He works at the Salvador Zubirán National Institute of Medical Sciences and Nutrition in Mexico City. Follow Dr. Soto on Twitter @EnriqueSoto8. There are more than 50 million people of Hispanic descent living in theRead More →
